News
New research reveals that tiny amounts of PFAS—widely known as "forever chemicals"—cross the placenta and breast milk to ...
4h
News-Medical.Net on MSNForever chemicals cross placenta and breast milk affecting babies’ immunityNew research reveals that tiny amounts of PFAS-widely known as "forever chemicals"-cross the placenta and breast milk to ...
Among the patients treated was 49-year-old lady from Odisha, diagnosed with acute B-cell lymphoblastic leukemia. After receiving the customized therapy, she showed significant recovery and was ...
The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.
Researchers recommend that details on prescription medications received in the year before diagnosis and treatment initiation be included in clinical trials as essential baseline information.
AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard ...
FDA issues a complete response letter for glofitamab's second-line DLBCL indication, highlighting ongoing scrutiny in ...
Glofitamab is a bispecific CD20-directed CD3 T-cell engager approved under the brand name Columvi ® for the treatment of adults with R/R DLBCL, not otherwise specified or large B-cell lymphoma arising ...
Thinning hair has many possible causes, and understanding why it happens is the key to successful treatment. An expert guide ...
5d
Zacks Investment Research on MSNRegeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold?Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock has underperformed the medical sector and S&P 500 Index in this timeframe.
Most B cells in peripheral lymphoid tissues are produced in adult bone marrow and are referred to as B-2 cells. A minor B-cell population, known as the B-1-cell population, that is mainly involved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results